Publications by authors named "Yingqi Lin"

Background: HD is a devastating neurodegenerative disorder caused by the expansion of CAG repeats in the HTT. Silencing the expression of mutated proteins is a therapeutic direction to rescue HD patients, and recent advances in gene editing technology such as CRISPR/CasRx have opened up new avenues for therapeutic intervention.

Methods: The CRISPR/CasRx system was employed to target human HTT exon 1, resulting in an efficient knockdown of HTT mRNA.

View Article and Find Full Text PDF

Both ursolic acid (UA) and sorafenib (Sora) have been generally utilized in cancer treatment, and the combination of the two has also shown a good anti-tumor effect. However, single-agent therapy for Hepatocellular carcinoma (HCC) has the disadvantages of multi-drug resistance, poor water solubility and low bioavailability, and the application of traditional nanocarrier materials is limited due to their low drug loading and low carrier-related toxicity. Therefore, we prepared US NPs with different proportions of UA and Sora by solvent exchange method for achieving synergistic HCC therapy.

View Article and Find Full Text PDF

The effectiveness of chemotherapeutic agents for hepatocellular carcinoma (HCC) is unsatisfactory because of tumor heterogeneity, multidrug resistance, and poor target accumulation. Therefore, multimodality-treatment with accurate drug delivery has become increasingly popular. Herein, a cell penetrating peptide-aptamer dual modified-nanocomposite (USILA NPs) was successfully constructed by coating a cell penetrating peptide and aptamer onto the surface of sorafenib (Sora), ursolic acid (UA) and indocyanine green (ICG) condensed nanodrug (USI NPs) via one-pot assembly for targeted and synergistic HCC treatment.

View Article and Find Full Text PDF

Tauopathy, characterized by the hyperphosphorylation and accumulation of the microtubule-associated protein tau, and the accumulation of Aβ oligomers, constitute the major pathological hallmarks of Alzheimer's disease. However, the relationship and causal roles of these two pathological changes in neurodegeneration remain to be defined, even though they occur together or independently in several neurodegenerative diseases associated with cognitive and movement impairment. While it is widely accepted that Aβ accumulation leads to tauopathy in the late stages of the disease, it is still unknown whether tauopathy influences the formation of toxic Aβ oligomers.

View Article and Find Full Text PDF
Article Synopsis
  • Accumulation of misfolded proteins, like mutant huntingtin in Huntington's disease (HD), leads to neuronal damage; targeting these proteins could be an effective treatment.
  • Researchers developed an intracellular antibody fragment (intrabody) that specifically binds to mutant huntingtin and promotes its degradation through lysosomes.
  • Administering this intrabody in HD model mice successfully cleared mutant proteins, reduced gliosis, and improved motor function, highlighting its potential as a new treatment for neurodegenerative diseases.
View Article and Find Full Text PDF

Severe combined immunodeficiency (SCID) encompasses a range of inherited disorders that lead to a profound deterioration of the immune system. Among the pivotal genes associated with SCID, RAG1 and IL2RG play crucial roles. IL2RG is essential for the development, differentiation, and functioning of T, B, and NK cells, while RAG1 critically contributes to adaptive immunity by facilitating V(D)J recombination during the maturation of lymphocytes.

View Article and Find Full Text PDF

CRISPR/Cas9 genome editing is a promising therapeutic technique, which makes precise and rapid gene editing technology possible on account of its high sensitivity and efficiency. CRISPR/Cas9 system has been proved to able to effectively disrupt and modify genes, which shows great potential for cancer treatment. Current researches proves that virus vectors are capable of effectively delivering the CRISPR/Cas9 system, but immunogenicity and carcinogenicity caused by virus transmission still trigger serious consequences.

View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the potential of gene therapy for Huntington's disease (HD) by replacing harmful genetic mutations with normal sequences in genetically engineered pigs.
  • A one-time injection of a virus carrying the Cas9 gene-editing tool and a guide targeting the mutant HTT gene led to a significant reduction of the mutated protein and improved neurological symptoms in the pigs.
  • The results suggest that similar gene therapy approaches could be effective in treating not just HD, but other genetic neurodegenerative diseases as well.
View Article and Find Full Text PDF

Objective: Uterine corpus endometrial carcinoma (UCEC) is a frequent epithelial cancer in females. The rate of UCEC occurrence increases year by year and the age is getting younger and younger, which requires more active treatments to improve its prognosis. Ferroptosis is a kind of regulatory cell death that relies on iron and may be triggered by sorafenib, which has been elucidated in several cancers, but the mechanism of ferroptosis-related genes in UCEC has yet to be fully defined and will need more investigation.

View Article and Find Full Text PDF
Article Synopsis
  • Animal models, particularly pigs, are key for studying human diseases and testing new drugs, especially in areas like cardiovascular and neurological research.
  • Pigs' brain structure closely resembles humans', making them valuable for investigating neurodegenerative diseases.
  • The study finds that intravenous delivery of AAV9-GFP effectively expresses transgenes in pigs' brains without causing inflammation, indicating potential for developing large animal models for gene mutation-related neurodegenerative diseases.
View Article and Find Full Text PDF

The foundation for investigating the mechanisms of human diseases is the establishment of animal models, which are also widely used in agricultural industry, pharmaceutical applications, and clinical research. However, small animals such as rodents, which have been extensively used to create disease models, do not often fully mimic the key pathological changes and/or important symptoms of human disease. As a result, there is an emerging need to establish suitable large animal models that can recapitulate important phenotypes of human diseases for investigating pathogenesis and developing effective therapeutics.

View Article and Find Full Text PDF
Article Synopsis
  • ALS and FTLD are severe neurodegenerative diseases characterized by the accumulation of TDP-43 protein, with no known cure available.
  • Tetramethylpyrazine nitrone (TBN), derived from traditional Chinese medicine, shows potential therapeutic effects and is currently in clinical trials for ALS.
  • In studies with ALS/FTLD mouse models, TBN improved motor and cognitive functions and increased survival rates, likely by activating specific cellular signaling pathways.
View Article and Find Full Text PDF

In vitro cultures of primary cortical neurons are widely used to investigate neuronal function. However, it has yet to be fully investigated whether there are significant differences in development and function between cultured rodent and primate cortical neurons, and whether these differences influence the utilization of cultured cortical neurons to model pathological conditions. Using in vitro culture techniques combined with immunofluorescence and electrophysiological methods, our study found that the development and maturation of primary cerebral cortical neurons from cynomolgus monkeys were slower than those from mice.

View Article and Find Full Text PDF

Monogenic mutations in the SHANK3 gene, which encodes a postsynaptic scaffold protein, play a causative role in autism spectrum disorder (ASD). Although a number of mouse models with Shank3 mutations have been valuable for investigating the pathogenesis of ASD, species-dependent differences in behaviors and brain structures post considerable challenges to use small animals to model ASD and to translate experimental therapeutics to the clinic. We have used clustered regularly interspersed short palindromic repeat/CRISPR-associated nuclease 9 to generate a cynomolgus monkey model by disrupting SHANK3 at exons 6 and 12.

View Article and Find Full Text PDF

Objective: To study the expressions of FXR, PPARa and Bile acid metabolism related genes in intrahepatic cholestasis of pregnant rats.

Methods: 60 clean SD pregnant rats were selected and divided randomly into three groups. Since the 13th day of pregnancy rats in control group were injected subcutaneously with refined vegetable oil 2.

View Article and Find Full Text PDF

Objective: To investigate the relationship between interaction of peroxisome proliferators-activated receptor alpha (PPARα), cytochrome P450 oxysterol 7α-hydroxylase (CYP7B1) and estrogen receptor (ER) and intrahepatic cholestasis in pregnant rats.

Methods: Eighty clean SD pregnant rats were selected and divided into four groups randomly with 20 in each. Since the 13th day of pregnancy, rats in the control group was injected subcutaneously with refined vegetable oil 2.

View Article and Find Full Text PDF